Mission Tumor: AE37

Oncology targets, strategies, cancer drug development and personalized medicine

Pages

Home
Website Use Notice and PDF printing help

Showing posts with label AE37. Show all posts

Wednesday, April 4, 2012

Breast Cancer Tweets From AACR 2012 Annual Meeting

AACR 2012 meeting summary - Breast cancer

Most Read 30 day

Midline Carcinoma, a Cancer Without a Cure: No More
Health Costs of Smoking and Prop 29
Cancer Fundraising and Advocacy: Audience Matters
Verastem brings CSC target into “sharper” focus
How does ARIAD's Ponatinib (Iclusig) Work
Cost of Cancer Drug Development, 4 Billion. Cost to Patient, 0.1 Million. Benefit, Priceless! Business Model, Unsustainable
Dogs Teaching Us a Thing or Two About Cancer Biology
Blog Update

About Me

View my complete profile

Blog Archive

▼ 2015 (1)
- ▼ Oct 2015 (1)
  - Blog Update

► 2014 (5)
- ► Jun 2014 (2)
- ► Apr 2014 (2)
- ► Jan 2014 (1)

► 2013 (18)
- ► Nov 2013 (2)
- ► Oct 2013 (4)
- ► Sep 2013 (2)
- ► Jun 2013 (3)
- ► May 2013 (3)
- ► Apr 2013 (2)
- ► Feb 2013 (2)

► 2012 (33)
- ► Oct 2012 (1)
- ► Jul 2012 (4)
- ► Jun 2012 (10)
- ► May 2012 (1)
- ► Apr 2012 (6)
- ► Mar 2012 (7)
- ► Jan 2012 (4)

► 2011 (29)
- ► Dec 2011 (8)
- ► Nov 2011 (1)
- ► Oct 2011 (2)
- ► Sep 2011 (2)
- ► Jul 2011 (2)
- ► Jun 2011 (2)
- ► May 2011 (2)
- ► Apr 2011 (1)
- ► Mar 2011 (3)
- ► Feb 2011 (5)
- ► Jan 2011 (1)

► 2010 (22)
- ► Dec 2010 (4)
- ► Nov 2010 (7)
- ► Oct 2010 (11)

Visitors since the begining of time

Tags

2DG 5FU aaRSs abiraterone abraxane AE37 afinitor agensys agios AGS-16M8F alk AMD Aminoacyl tRNA synthases AML anastrozole angiogenesis angiogenic switch anti-angiogenesis anti-EGFR anti-EGFR MABs apoptone app arn509 aromasin art astellas avastin aveo basal cell carcinoma bayer BCR-ABL bevacizumab bidil biogen idec biomarkers biosimilars biotech biz bisphosphonates book bortezomib brachytherapy BRAF brca breast cancer bromodomain proteins c-kit CABERNET trial cancer advocacy cancer charity cancer diagnosis cancer genome cancer immunology cancer incidence cancer metabolism cancer moa cancer stem cells cancer survival cancer target canine canSAR carcinogenesis CD80 CDx celgene cervarix cetuximab charity chemotherapy choroidal neovascularization circulating tumor cells clinical trial CML CNV codeine colon cancer comparative oncology conference cornerstone pharma CPI-613 cremophor cripto crizotinib crpc csc CT scan CTC custirsen cyp17A1 database dendreon diabetes diagnosis docetaxel dogs drug cost drug counterfeit drug development drug discovery drug pricing dual HER-2 inhibition earthquake economics egfr EML4-ALK emotional support endothelial cells environmental factors epidemiology erbitux erlotinib ET everolimus evoerolimus exemesrane FAQs fda fda guidance Fn14 focus issue FOLFIRI FOLFIRINOX folkman fulvestrant funding fundraising galiximab gardasil gemcitabine gemzar genentech getifinib giving grants great minds greetings hayw hedgehog hepatocellular carcinoma her2 herbs herceptin ibrutinib IDH1 IL2 immunotherapy INC424 interesting interferon-a ipilimumab Istodax JAK-STAT JAK2 JAK2(V617F) japan jevtana JQ1 JQ2 kgf-1 kidney KRAS lapatinib LBH589 LDH-A leadership legislation lestaurtinib leukemia list literature liver liver cancer Lucentis lung cancer lymphoma maiblog mammography mapk MCT1 mdv3100 medivation meeting report melanoma mesothelioma metastatic midline carcinoma mirna mki Mo99 MPN mTOR mucositis multiple myeloma mutations myc myeloproliferative disorders nexavar ngs nimotuzumab notch NRU NSCLC nuclear medicine oncolytic viruses oncomed onyx oral oral-mucositis ovarian cancer paclitaxel pain palliative care pancreatic cancer panitumumab panobinostat patent patient care pdgf pelifermin pericytes personalized medicine pertuzumab pets Petten pfizer PGx pharmacogenomics phase 2 trial phase 3 trial PHY906 PKM2 PMF politics ponatinib presentation Prop 29 prostate cancer provenge pubmed PV Q and A radiation therapy radiodiagnosis radiotherapy radiotracer raf random finds ranibizumab rare cancers rcc red cross regulatory renal cancer renal cell carcinoma restructuring ret retinal diseases revlimid rituximab romidepsin ruxolitinib s1p screening second cancer SEER registry sendai sequencing side-effects sipuleucel-T skin cancer SMO antagonist social media sorafenib statistics steve jobs sunitinib supreme court sutent systems biology T-DM1 talks tarceva taxol Tc99m TG101348 thalidomide theracim therapeutic mabs thyroid thyroid cancer tivozanib tki tools tosocitinib trastuzumab TrpRS tsunami TTM Boston meeting tumor escape tumor microenvironment tumor models tweak tykerb update uranium vectibix vegf vemurafenib verastem video vismodegib volociximab vorinostat warburg xeloda yervoy zeitgeist Zelboraf Zolinza zytiga

AddThis

AlexaStats

My Blog List

Lifehacker

Turn Your Phone Into a Gaming Console With This $90 Snap-On Controller
KevinMD.com

Locum tenens: Reclaiming purpose, autonomy, and financial freedom in medicine
BioCentury

How Tallon plans to make MHRA a pillar of U.K. life sciences competitiveness
Forbes - Pharma & Healthcare

Epic Faces Antitrust Challenge As Lawsuit Proceeds
The Concord Review - Will's Blog

INDIAN STUDENT
Sandwalk

Endogenous retrovirus sequences can be transcriptionally active: the reality vs. the hype
Biotech Blog

Making Medicines Affordable: The Role of Generics
Live with Flair

To Remind You This Isn’t Home
Medgadget

Plant-Based Soft Medical Robots
Xconomy

Watch ‘Jesus Revolution’ (Free) Online Streaming HBO Here’s How!
EurekAlert

Through the thin-film glass, researchers spot a new liquid phase
Cancer Network

Phase III KEYNOTE-361 Trial Fails to Meet Primary End Points
Cancer Stem Cell News

Examples of Research on CSCs during 2019
BIOtech NOW

Nobody Puts Corn in the Corner
Coffee and Sci(ence)

Molecular control of macroscopic forces drives formation of the vertebrate hindgut.
Society of Chemical Industry - News

Phase 1 of the new SCI website is coming shortly
Wolfram|Alpha Blog

Find All Wolfram News in One Place—The Wolfram Blog
PharmaGossip

Oh dear ASDA
Radio Free Meredith

Sadism, trolley problems and fire ants
The IN VIVO Blog

IN VIVO Blog Is No More.
WSJ.com: Health Blog

Is a Paleo Diet Healthier Than Standard Nutritional Guidelines?
Being Cancer Network

I’m Baaack!
The Chart

1 in 7 suffer from sleep 'drunkenness'
The Scientific Cartoonist

NP-hard
Pharma Strategy Blog

Developing a predictive biomarker for PARP inhibition
C&EN's The Haystack

Roche’s GA101 (obinutuzumab): Engineering an antibody to beat Rituxan
Biotech SF

Stanford team wins $20K for algorithm aimed at Lou Gehrig's disease drug trials
pipet2pen

Handwriting is on the Wall
Hematopoiesis

Stem Cell Autopsy: The first teratoma case unfolded
KinasePro

iKinase
The Great Beyond (Nature News)
Pharmalot
Gary Schwitzer's HealthNewsReview Blog
Stand Up To Cancer
Tumors Galore
CureToday.com
StemCellDigest - Cancer
Bio Job Blog

Show 10 Show All